| Literature DB >> 21686079 |
Thomas V Johnson1, Natalie D Bull, Keith R Martin.
Abstract
Glaucoma is a progressive, neurodegenerative, optic neuropathy in which currently available therapies cannot always prevent, and do not reverse, vision loss. Stem cell transplantation may provide a promising new avenue for treating many presently incurable degenerative conditions, including glaucoma. This article will explore the various ways in which transplantation of stem or progenitor cells may be applied for the treatment of glaucoma. We will critically discuss the translational prospects of two cell transplantation-based treatment modalities: neuroprotection and retinal ganglion cell replacement. In addition, we will identify specific questions that need to be addressed and obstacles to overcome on the path to clinical translation, and offer insight into potential strategies for approaching this goal.Entities:
Year: 2011 PMID: 21686079 PMCID: PMC3114633 DOI: 10.1586/eop.11.3
Source DB: PubMed Journal: Expert Rev Ophthalmol ISSN: 1746-9899